微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Nuclear pollyhedrosis virus, Autographa californica (Recombinant) |
|---|---|
| 商品货号： | TS213927 |
| Classification： | Baculovirus, recombinant |
| Agent： | Nuclear pollyhedrosis virus, Autographa californica (Recombinant) |
| Strain： | DR-AcNPV |
| Applications： | Virus expresses 1,25-dihydroxyvitamin D3 receptor protein. |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Genetically Engineered Baculovirus |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Virus expresses 1,25-dihydroxyvitamin D3 receptor protein. Propagation of the virus is performed at a MOI of 1-10. Virus should remain viable for 10 years when stored at 4C. |
| Effect on Host： | Cytopathic effects (plaque formation); no polyhedrin occlusions |
| Recommended Host： | Sf9 cells (ATCC CRL-1711); SF-21 cells Sf9 cells (ATCC CRL-1711); Sf21 cells |
| Growth Conditions： | Temperature: 27°C Incubation: 3-5 days |
| Name of Depositor： | HF DeLuca, TK Ross, JM Prahl |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Genetically Engineered Baculovirus |
| References： | DeLuca HF, et al. Method of producing 1,25-dihydroxyvitamin D.sub.3 receptor protein. US Patent 5,260,199 dated Nov 9 1993 |